<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Dermatofibroma (benign fibrous histiocytoma)
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Dermatofibroma (benign fibrous histiocytoma)
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Dermatofibroma (benign fibrous histiocytoma)
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            JiaDe Yu, MD, MS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert P Dellavalle, MD, PhD, MSPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rosamaria Corona, MD, DSc
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 14, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H53511570">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dermatofibroma, also known as benign fibrous histiocytoma, is a common soft tissue lesion due to the proliferation of benign spindle cells within the dermis [
         <a href="#rid1">
          1
         </a>
         ]. Dermatofibromas usually occur on the extremities and are more common in females. Various histologic subtypes of dermatofibromas exist. Treatment is usually not necessary.
        </p>
        <p>
         This topic will discuss the clinical manifestations, diagnosis, and treatment of dermatofibroma. An overview of other benign skin lesions is provided separately. (See
         <a class="medical medical_review" href="/z/d/html/5573.html" rel="external">
          "Overview of benign lesions of the skin"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4119936013">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dermatofibromas are one of the most common cutaneous lesions. The exact prevalence is difficult to measure since most patients do not seek care for these lesions due to their asymptomatic nature. Dermatofibromas usually appear in patients between 20 to 40 years of age (with a female predominance) but have been reported in all age groups [
         <a href="#rid2">
          2,3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2649849434">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The exact pathogenesis of dermatofibromas is debated and unknown. Most dermatofibromas are thought to be a reactive process secondary to local trauma including, but not limited to, insect bites, puncture wounds due to splinters, and ingrown hairs. However, some authors also believe that dermatofibromas are a spontaneous, benign, neoplastic process with evidence of clonal proliferation [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2884508279">
         <span class="h1">
          CLINICAL PRESENTATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dermatofibromas present as slow growing, pink or tan/brown to black, firm, dermal papules usually measuring &lt;2 cm in diameter, most often located on the limbs  (
         <a class="graphic graphic_picture graphicRef80587" href="/z/d/graphic/80587.html" rel="external">
          picture 1A
         </a>
         ) [
         <a href="#rid4">
          4
         </a>
         ]. In individuals with darkly pigmented skin, dermatofibromas appear as dark brown to black papules  (
         <a class="graphic graphic_picture graphicRef68729" href="/z/d/graphic/68729.html" rel="external">
          picture 1B
         </a>
         ). Rarely, a dermatofibroma may appear as an atrophic, depressed lesion [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         The age of onset is usually in early to mid-adulthood, but dermatofibromas may also occur in children [
         <a href="#rid3">
          3
         </a>
         ]. In most cases, dermatofibromas are solitary lesions, although multiple lesions can occur [
         <a href="#rid2">
          2,6
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Multiple dermatofibromas
         </strong>
         – Multiple dermatofibromas are defined as &gt;15 discrete lesions appearing in a few months on the extremities and trunk. Multiple dermatofibromas have been associated with underlying systemic diseases, including autoimmune diseases, malignancies, and human immunodeficiency virus (HIV) infection; immunosuppressive or immunomodulating therapies; and pregnancy [
         <a href="#rid7">
          7,8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Multiple eruptive dermatofibromas
         </strong>
         – In rare cases, multiple dermatofibromas can appear over a period of a few months in different areas of the body [
         <a href="#rid8">
          8
         </a>
         ]. In most cases, they are associated with an underlying autoimmune disorder or immunodeficiency [
         <a href="#rid9">
          9-11
         </a>
         ], but they can be idiopathic [
         <a href="#rid12">
          12,13
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Multiple clustered dermatofibromas
         </strong>
         – Multiple clustered dermatofibromas are an extremely rare clinical variant of dermatofibroma. They present as a plaque composed of multiple (&gt;15) reddish to hyperpigmented papules, most often located on the lower extremities or trunk [
         <a href="#rid6">
          6,14
         </a>
         ]. There are several reports of congenital multiple clustered dermatofibromas [
         <a href="#rid15">
          15-18
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H811448890">
         <span class="h1">
          HISTOPATHOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         On routine histopathologic examination, common dermatofibromas show dermal proliferation of uniform spindle cells (fibroblast like and histiocyte like) separated from the overlying epidermis by a clear grenz zone. A variable mononuclear inflammatory infiltrate is also present. Collagen trapping may be noted in the periphery of the lesion. The overlying epidermis shows acanthosis with hyperpigmentation of the basal layer (dirty feet sign).
        </p>
        <p>
         Immunohistochemical staining is positive for factor XIIIa, SMA, and vimentin and negative for CD34 and S100  (
         <a class="graphic graphic_table graphicRef73370" href="/z/d/graphic/73370.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H4067197927">
         <span class="h1">
          RARE CLINICOPATHOLOGIC VARIANTS
         </span>
        </p>
        <p class="headingAnchor" id="H3560195291">
         <span class="h2">
          Cellular dermatofibroma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cellular dermatofibroma is an uncommon variant of dermatofibroma, representing less than 5 percent of dermatofibromas [
         <a href="#rid19">
          19
         </a>
         ]. It is usually larger in size than the common dermatofibroma and may resemble early dermatofibrosarcoma protuberans (see
         <a class="medical medical_review" href="/z/d/html/7747.html" rel="external">
          "Dermatofibrosarcoma protuberans: Epidemiology, pathogenesis, clinical presentation, diagnosis, and staging"
         </a>
         ). Histologically, cellular dermatofibroma shows dense proliferation of fibrohistiocytic cells that display a swirling, storiform pattern with extension into the subcutaneous fat. Fat necrosis associated with lymphocytic infiltrate is often noted [
         <a href="#rid20">
          20
         </a>
         ]. Cellular dermatofibroma has a higher risk of recurrence (approximately 10 percent) if incompletely excised [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1434943770">
         <span class="h2">
          Epithelioid dermatofibroma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Epithelioid dermatofibroma clinically presents as a polypoid, red papule or nodule with an epidermal collarette that may mimic amelanotic melanoma or nonulcerated pyogenic granuloma. Histologically, epithelioid dermatofibroma is composed of large, angulated, epithelioid cells with abundant eosinophilic cytoplasm that may be confused with an intradermal Spitz nevus [
         <a href="#rid22">
          22
         </a>
         ]. However, in contrast with Spitz nevus, immunohistochemical staining of epithelioid dermatofibroma with S100 is always negative. Several studies have demonstrated
         <em>
          ALK
         </em>
         rearrangements and ALK overexpression in most epithelioid dermatofibromas, suggesting that they may be biologically distinct entities [
         <a href="#rid23">
          23-25
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13523.html" rel="external">
          "Spitz nevus and atypical Spitz tumors", section on 'Immunohistochemistry'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2261556554">
         <span class="h2">
          Aneurysmal/hemosiderotic dermatofibroma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Aneurysmal dermatofibromas present as brown/blue papules, usually located on the lower legs. They may grow rapidly, ulcerate, and bleed. The clinical diagnosis is difficult, as these lesions can mimic melanoma, vascular tumors, or adnexal tumors (among others) [
         <a href="#rid26">
          26
         </a>
         ]. Histologically, aneurysmal dermatofibroma is a spindle-cell tumor with cleft-like, blood-filled spaces; focal hemorrhage; and hemosiderin deposition [
         <a href="#rid22">
          22
         </a>
         ]. Hemosiderotic dermatofibroma is considered by some an early stage of aneurysmal dermatofibroma. The lesion is composed of numerous small vessels, extravasated red blood cells, and intra- and extracellular hemosiderin deposition.
        </p>
        <p class="headingAnchor" id="H3505834273">
         <span class="h2">
          Other
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other uncommon variants of dermatofibroma include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lipidized dermatofibroma
         </strong>
         – Lipidized dermatofibroma presents as an exophytic, yellowish nodule, usually larger than common dermatofibromas and most often located on the lower legs (ankle-type fibrous histiocytomas) [
         <a href="#rid27">
          27
         </a>
         ]. Histologically, this variant demonstrates foamy histiocytes with hyalinization of the collagen. There are no reports of recurrence after excision.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atypical dermatofibroma (dermatofibroma with monster cells)
         </strong>
         – Atypical dermatofibroma is a rare histologic variant characterized by large, pleiomorphic cells with large, bizarre, and hyperchromatic nuclei (also referred to as "monster cells").
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Metastasizing dermatofibroma
         </strong>
         – Metastasizing benign dermatofibroma is an exceedingly rare variant that may have the clinical and pathologic features of cellular, aneurysmal, or atypical dermatofibroma [
         <a href="#rid28">
          28-30
         </a>
         ]. These lesions are usually larger than common dermatofibromas (&gt;3 cm) and tend to recur locally after excision. In a series of 16 cases, metastases involved the lungs, lymph nodes, soft tissues, and liver, and six patients died of disease [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4082761655">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of dermatofibromas is usually made clinically, based on clinical appearance and history. If the lesion is longstanding, it should have no history of rapid change. Dermatofibromas characteristically exhibit the "dimple sign," where the lesions dimple centrally when lateral pressure is exerted  (
         <a class="graphic graphic_picture graphicRef142420 graphicRef80575" href="/z/d/graphic/142420.html" rel="external">
          picture 2A-B
         </a>
         ).
        </p>
        <p>
         Dermoscopic examination may support the clinical diagnosis. It typically shows a peripheral, delicate pigment network with a central, scar-like area  (
         <a class="graphic graphic_picture graphicRef67214" href="/z/d/graphic/67214.html" rel="external">
          picture 3
         </a>
         ).
        </p>
        <p>
         Rapidly changing lesions, symptomatic lesions, and lesions showing atypical features should be biopsied to rule out atypical variants or other neoplasms. (See
         <a class="local">
          'Rare clinicopathologic variants'
         </a>
         above and
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1010108751">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical differential diagnosis for dermatofibromas is broad and includes the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dermatofibrosarcoma protuberans
         </strong>
         – Dermatofibrosarcoma protuberans
         <strong>
         </strong>
         is a locally aggressive, slow growing tumor that can be mistaken for a benign dermatofibroma (especially at early stages)  (
         <a class="graphic graphic_picture graphicRef100252 graphicRef135226" href="/z/d/graphic/100252.html" rel="external">
          picture 4A-B
         </a>
         ). Histologic differentiation is key as dermatofibrosarcoma protuberans has a higher mitotic rate and displays positive staining for CD34 and negative staining for factor XIIIa (opposite of a benign dermatofibroma)  (
         <a class="graphic graphic_table graphicRef73370" href="/z/d/graphic/73370.html" rel="external">
          table 1
         </a>
         ). Dermatofibrosarcoma protuberans lesions tend to be large, with an average size &gt;5 cm. (See
         <a class="medical medical_review" href="/z/d/html/7747.html" rel="external">
          "Dermatofibrosarcoma protuberans: Epidemiology, pathogenesis, clinical presentation, diagnosis, and staging"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intradermal nevi
         </strong>
         – Intradermal nevi  (
         <a class="graphic graphic_picture graphicRef76961" href="/z/d/graphic/76961.html" rel="external">
          picture 5
         </a>
         ) are benign, melanocytic tumors that are softer than dermatofibromas and do not exhibit the "dimple sign" when pinched. (See
         <a class="medical medical_review" href="/z/d/html/4846.html" rel="external">
          "Acquired melanocytic nevi (moles)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Basal cell carcinoma
         </strong>
         – Early nodular basal cell carcinoma (BCC) typically presents as a pink, skin-colored, or pigmented papule, most often located on the face  (
         <a class="graphic graphic_picture graphicRef121465 graphicRef121466" href="/z/d/graphic/121465.html" rel="external">
          picture 6A-B
         </a>
         ). Dermoscopy shows arborizing vessels, blue-gray globules and dots, and small erosions  (
         <a class="graphic graphic_picture graphicRef61313" href="/z/d/graphic/61313.html" rel="external">
          picture 7
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5335.html" rel="external">
          "Basal cell carcinoma: Epidemiology, pathogenesis, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3822511933">
         <span class="h1">
          TREATMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         No treatment is usually required for asymptomatic, static, common dermatofibromas. Surgical excision is not advised for common dermatofibromas, as it results in a scar that will likely appear worse than the original lesion. For patients who desire treatment for cosmetic concerns, we suggest cryotherapy with liquid nitrogen rather than surgical excision. Cryotherapy has been tried with some success for protuberant lesions with resolution or flattening of the lesion with good cosmetic results [
         <a href="#rid31">
          31,32
         </a>
         ].
        </p>
        <p>
         Atypical variants have a higher risk of recurrence, and a complete excision with clear margins should be performed. (See
         <a class="local">
          'Rare clinicopathologic variants'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H210395040">
         <span class="h1">
          PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dermatofibromas are usually benign, static, asymptomatic lesions that exhibit little to no growth. Spontaneous resolution is rarely reported and is the exception.
        </p>
        <p>
         Atypical variants (eg, cellular, epithelioid, aneurysmal) may recur locally after surgical excision and, in exceptionally rare cases, metastasize.
        </p>
        <p class="headingAnchor" id="H993370209">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         – Dermatofibroma, also known as benign fibrous histiocytoma, is a common soft tissue lesion due to the proliferation of benign spindle cells within the dermis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Dermatofibromas present as slow growing or static, pink or tan/brown to black, firm, dermal papules usually measuring &lt;2 cm in diameter, most often located on the limbs  (
         <a class="graphic graphic_picture graphicRef80587 graphicRef68729" href="/z/d/graphic/80587.html" rel="external">
          picture 1A-B
         </a>
         ). Lesions are usually solitary. The development of multiple lesions has been associated with autoimmune disorders, immunodeficiency, or malignancy. (See
         <a class="local">
          'Clinical presentation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Rare clinicopathologic variants of dermatofibroma include cellular, epithelioid, aneurysmal/hemosiderotic, lipidized, and atypical dermatofibromas. (See
         <a class="local">
          'Rare clinicopathologic variants'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis is usually made clinically, based on clinical appearance and history. Dermatofibromas characteristically exhibit the "dimple sign," where the lesions dimple centrally when lateral pressure is exerted  (
         <a class="graphic graphic_picture graphicRef142420 graphicRef80575" href="/z/d/graphic/142420.html" rel="external">
          picture 2A-B
         </a>
         ). Dermoscopy typically shows a peripheral, delicate pigment network with a central, scar-like area  (
         <a class="graphic graphic_picture graphicRef67214" href="/z/d/graphic/67214.html" rel="external">
          picture 3
         </a>
         ). Rapidly changing, symptomatic, or atypical lesions should be biopsied to rule out atypical variants or other neoplasms. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – Treatment differs for common versus atypical lesions. (See
         <a class="local">
          'Treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         No treatment is usually required for asymptomatic, static, common dermatofibromas. However, for patients who desire treatment for cosmetic concerns, we suggest cryotherapy with liquid nitrogen rather than surgical excision (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For lesions that were biopsied and confirmed histologically as atypical variants, we suggest surgical excision rather than observation or cryotherapy (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Clear margins must be obtained; otherwise, recurrence is common.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Chen TC, Kuo T, Chan HL. Dermatofibroma is a clonal proliferative disease. J Cutan Pathol 2000; 27:36.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Han TY, Chang HS, Lee JH, et al. A clinical and histopathological study of 122 cases of dermatofibroma (benign fibrous histiocytoma). Ann Dermatol 2011; 23:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berklite L, Ranganathan S, John I, et al. Fibrous histiocytoma/dermatofibroma in children: the same as adults? Hum Pathol 2020; 99:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pusztaszeri M, Jaquet PY, Williamson C. Giant hemosiderotic dermatofibroma: a case report and review of the literature. Case Rep Dermatol 2011; 3:32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen PR, Erickson CP, Calame A. Atrophic Dermatofibroma: A Comprehensive Literature Review. Dermatol Ther (Heidelb) 2019; 9:449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seifi G, Kalantari Y, Etesami I. Multiple dermatofibromas, associated clinical and histological characteristics: A systematic review. J Dtsch Dermatol Ges 2022; 20:1569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beatrous SV, Riahi RR, Grisoli SB, Cohen PR. Associated conditions in patients with multiple dermatofibromas: Case reports and literature review. Dermatol Online J 2017; 23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Niiyama S, Katsuoka K, Happle R, Hoffmann R. Multiple eruptive dermatofibromas: a review of the literature. Acta Derm Venereol 2002; 82:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ridha Z, Belmesk L, Jfri A, et al. Systemic Disease Association With Multiple Eruptive Dermatofibromas: A Systematic Review. J Cutan Med Surg 2022; 26:628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           An İ, Devran Gevher Ö, Esen M, et al. Multiple Eruptive Dermatofibromas in a Patient With Systemic Lupus Erythematosus Treated With Methylprednisolone. Arch Rheumatol 2018; 33:236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Callahan S, Matires K, Shvartsbeyn M, Brinster N. Multiple eruptive dermatofibromas. Dermatol Online J 2015; 21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Her Y, Ku SH, Kim KH. A case of multiple eruptive dermatofibromas in a healthy adult. Ann Dermatol 2014; 26:539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marque M, Pallure V, Huet P, et al. [Multiple familial "eruptive" dermatofibromas]. Ann Dermatol Venereol 2013; 140:452.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gershtenson PC, Krunic AL, Chen HM. Multiple clustered dermatofibroma: case report and review of the literature. J Cutan Pathol 2010; 37:e42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pinto-Almeida T, Caetano M, Alves R, Selores M. Congenital multiple clustered dermatofibroma and multiple eruptive dermatofibromas--unusual presentations of a common entity. An Bras Dermatol 2013; 88:63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Higaki-Mori H, Yoshida Y, Hisaoka M, et al. Unusual Congenital Multiple Clustered Dermatofibroma: First Reported Case on the Face. Acta Derm Venereol 2019; 99:341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitri F, Haenssle H, Enk A, Toberer F. Congenital multiple clustered dermatofibroma on the abdomen. Br J Dermatol 2020; 183:e64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Finch J, Berke A, McCusker M, Chang MW. Congenital multiple clustered dermatofibroma in a 12-year-old girl. Pediatr Dermatol 2014; 31:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Calonje E, Mentzel T, Fletcher CD. Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence. Am J Surg Pathol 1994; 18:668.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schechter SA, Bresler SC, Patel RM. Fat necrosis with an associated lymphocytic infiltrate represents a histopathologic clue that distinguishes cellular dermatofibroma from dermatofibrosarcoma protuberans. J Cutan Pathol 2020; 47:913.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaufin M, Michaelis T, Duffy K. Cellular Dermatofibroma: Clinicopathologic Review of 218 Cases of Cellular Dermatofibroma to Determine the Clinical Recurrence Rate. Dermatol Surg 2019; 45:1359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alves JV, Matos DM, Barreiros HF, Bártolo EA. Variants of dermatofibroma--a histopathological study. An Bras Dermatol 2014; 89:472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Epithelioid Fibrous Histiocytoma: A Concise Review: Erratum. Am J Dermatopathol 2020; 42:628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doyle LA, Mariño-Enriquez A, Fletcher CD, Hornick JL. ALK rearrangement and overexpression in epithelioid fibrous histiocytoma. Mod Pathol 2015; 28:904.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kazlouskaya V, Ho J, Jedrych J, Karunamurthy A. Spindle cell variant of epithelioid cell histiocytoma (spindle cell histiocytoma) with ALK gene fusions: Cases series and review of the literature. J Cutan Pathol 2021; 48:837.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zaballos P, Álvarez-Salafranca M, Llambrich À, et al. Dermoscopy of haemosiderotic/aneurysmal dermatofibroma: A morphological study of 110 cases. J Eur Acad Dermatol Venereol 2023; 37:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu F, Wang H, Wu G, Li C. Clinical and pathological studies of eight cases of lipidized fibrous histiocytoma. Exp Ther Med 2023; 25:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doyle LA, Fletcher CD. Metastasizing "benign" cutaneous fibrous histiocytoma: a clinicopathologic analysis of 16 cases. Am J Surg Pathol 2013; 37:484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orzan OA, Dorobanțu AM, Gurău CD, et al. Challenging Patterns of Atypical Dermatofibromas and Promising Diagnostic Tools for Differential Diagnosis of Malignant Lesions. Diagnostics (Basel) 2023; 13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mentzel T, Wiesner T, Cerroni L, et al. Malignant dermatofibroma: clinicopathological, immunohistochemical, and molecular analysis of seven cases. Mod Pathol 2013; 26:256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lanigan SW, Robinson TW. Cryotherapy for dermatofibromas. Clin Exp Dermatol 1987; 12:121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spiller WF, Spiller RF. Cryosurgery in dermatologic office practice: special reference to dermatofibroma and mucous cyst of the lip. South Med J 1975; 68:157.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 142252 Version 1.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10660130" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Dermatofibroma is a clonal proliferative disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21747617" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : A clinical and histopathological study of 122 cases of dermatofibroma (benign fibrous histiocytoma).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32246988" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Fibrous histiocytoma/dermatofibroma in children: the same as adults?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21487458" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Giant hemosiderotic dermatofibroma: a case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31338755" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Atrophic Dermatofibroma: A Comprehensive Literature Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36464809" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Multiple dermatofibromas, associated clinical and histological characteristics: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29469716" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Associated conditions in patients with multiple dermatofibromas: Case reports and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12361125" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Multiple eruptive dermatofibromas: a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36082765" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Systemic Disease Association With Multiple Eruptive Dermatofibromas: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30207570" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Multiple Eruptive Dermatofibromas in a Patient With Systemic Lupus Erythematosus Treated With Methylprednisolone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26990339" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Multiple eruptive dermatofibromas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25143694" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : A case of multiple eruptive dermatofibromas in a healthy adult.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23773744" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : [Multiple familial "eruptive" dermatofibromas].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19614987" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Multiple clustered dermatofibroma: case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24346882" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Congenital multiple clustered dermatofibroma and multiple eruptive dermatofibromas--unusual presentations of a common entity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30543382" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Unusual Congenital Multiple Clustered Dermatofibroma: First Reported Case on the Face.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32390156" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Congenital multiple clustered dermatofibroma on the abdomen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22211625" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Congenital multiple clustered dermatofibroma in a 12-year-old girl.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8017561" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32412128" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Fat necrosis with an associated lymphocytic infiltrate represents a histopathologic clue that distinguishes cellular dermatofibroma from dermatofibrosarcoma protuberans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30741794" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Cellular Dermatofibroma: Clinicopathologic Review of 218 Cases of Cellular Dermatofibroma to Determine the Clinical Recurrence Rate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24937822" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Variants of dermatofibroma--a histopathological study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32701707" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Epithelioid Fibrous Histiocytoma: A Concise Review: Erratum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25857825" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : ALK rearrangement and overexpression in epithelioid fibrous histiocytoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33217002" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Spindle cell variant of epithelioid cell histiocytoma (spindle cell histiocytoma) with ALK gene fusions: Cases series and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36251407" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Dermoscopy of haemosiderotic/aneurysmal dermatofibroma: A morphological study of 110 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36761009" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Clinical and pathological studies of eight cases of lipidized fibrous histiocytoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23426120" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Metastasizing "benign" cutaneous fibrous histiocytoma: a clinicopathologic analysis of 16 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36832159" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Challenging Patterns of Atypical Dermatofibromas and Promising Diagnostic Tools for Differential Diagnosis of Malignant Lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22996372" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Malignant dermatofibroma: clinicopathological, immunohistochemical, and molecular analysis of seven cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3677469" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Cryotherapy for dermatofibromas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1118748" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Cryosurgery in dermatologic office practice: special reference to dermatofibroma and mucous cyst of the lip.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
